Patent ID: 9687552
Date: 2017-06-27
CPC Classifications: A61J,A61K,A61P

Claim:
1. A combination of poly(N-acryloylglycinamide) with at least one active principle and/or at least one product that is visible in medical imaging, in a physiologically acceptable aqueous medium, wherein said active principle is chosen from antitumor agents, antibiotics, analgesics, anti-inflammatory agents, growth factors and antiseptics, wherein said product that is visible in medical imaging is chosen from an opacifier, a fluorescer and an ionizing radiation emitter wherein the combination has a gel-sol transition temperature of between 30 and 60° C., and being in liquid form above the gel-sol transition temperature and in gel form below the gel-sol transition temperature, and the combination being useful (i) for local post-operative or preoperative treatment, (ii) for treating wounds, wherein it is applied directly to the wound or via any protective device, or (iii) for post-operative monitoring by medical imaging.